Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/683
Title: Atypical antipsychotic-induced diabetes mellitus: An update on epidemiology and postulated mechanisms
Authors: Morrow, A. F.
Buchholz, S.
Coleman, P. L.
Issue Date: 2008
Source: July 38 (7) , 2008, p. 602-606
Pages: 602-606
Journal: Internal Medicine Journal
Abstract: Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome are rare, but potentially fatal complications of antipsychotic-associated hyperglycaemia. The mechanisms for this remain unclear, but are probably multifactorial. The suggested reasons include drug-induced weight gain and adiposity, development of the metabolic syndrome, antagonism of serotonin (5-hydroxytryptamine) receptors, drug-induced leptin resistance, dyslipidaemia mediated pancreatic beta-cell damage and hepatocyte transcription factor dysregulation. Patients with schizophrenia are known to be at a higher genetic risk of developing diabetes mellitus and cardiovascular disease. This review emphasizes a rare case of hyperosmolar hyperglycaemic syndrome in a young man with schizophrenia and discusses proposed mechanisms for the development of antipsychotic-associated diabetes mellitus. 2008 The Authors.
Resources: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed8&AN=2008363610
Type: Article
Appears in Sites:Sunshine Coast HHS Publications

Show full item record

Page view(s)

128
checked on Jan 7, 2025

Google ScholarTM

Check


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.